Abstract
Cell line instability is a common problem in biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells. Cell line instability, which refers to unintended and unpredicted genetic, epigenetic, and phenotypic changes over time, can increase production costs and threaten sales approval by reducing product quantity and quality. While a stability test is conducted to screen cell lines with stable transgene expression, this process requires several months, delaying the entire drug development timeline. To accelerate timeline for drug development, understanding, mitigation, and prediction of cell line instability are critical. In this review, we update recent research progresses regarding instability-inducing biological mechanisms and alleviating the intrinsic instability of CHO cells. We also discuss studies that contribute to predicting irregular phenotypic changes in recombinant protein-producing CHO cell lines, based on omics-based studies. These prediction strategies will contribute to complementing current instability alleviating strategies, thereby saving labor, cost, and time for the cell line development process as well as providing a comprehensive understanding of CHO cell biology.
References
Walsh, G. and E. Walsh (2022) Biopharmaceutical benchmarks 2022. Nat. Biotechnol. 40: 1722–1760.
Wu, S., A. J. Rish, A. Skomo, Y. Zhao, J. K. Drennen, and C. A. Anderson (2021) Rapid serum-free/suspension adaptation: medium development using a definitive screening design for Chinese hamster ovary cells. Biotechnol. Prog. 37: e3154.
Huang, Y.-M., W. Hu, E. Rustandi, K. Chang, H. Yusuf-Makagiansar, and T. Ryll (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol. Prog. 26: 1400–1410.
Tihanyi, B. and L. Nyitray (2020) Recent advances in CHO cell line development for recombinant protein production. Drug Discov. Today Technol. 38: 25–34.
Zhang, Q., B. Jiang, L. Nelson, S. Huhn, Z. Du, and L. A. Chasin (2022) A multiauxotrophic CHO cell line for the rapid isolation of producers of diverse or high levels of recombinant proteins. Biotechnol. Bioeng. 119: 1392–1404.
Berting, A., M. R. Farcet, and T. R. Kreil (2010) Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing. Biotechnol. Bioeng. 106: 598–607.
Butler, M. and M. Spearman (2014) The choice of mammalian cell host and possibilities for glycosylation engineering. Curr. Opin. Biotechnol. 30: 107–112.
Lalonde, M.-E. and Y. Durocher (2017) Therapeutic glycoprotein production in mammalian cells. J. Biotechnol. 251: 128–140.
Kelley, B. (2020) Developing therapeutic monoclonal antibodies at pandemic pace. Nat. Biotechnol. 38: 540–545.
Kunert, R. and D. Reinhart (2016) Advances in recombinant antibody manufacturing. Appl. Microbiol. Biotechnol. 100: 3451–3461.
Dumont, J., D. Euwart, B. Mei, S. Estes, and R. Kshirsagar (2016) Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 36:1110–1122.
Welch, J. T. and N. S. Arden (2019) Considering “clonality”: a regulatory perspective on the importance of the clonal derivation of mammalian cell banks in biopharmaceutical development. Biologicals 62: 16–21.
Dahodwala, H. and K. H. Lee (2019) The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem. Curr. Opin. Biotechnol. 60: 128–137.
Dorai, H., S. Corisdeo, D. Ellis, C. Kinney, M. Chomo, P. Hawley-Nelson, G. Moore, M. J. Betenbaugh, and S. Ganguly (2012) Early prediction of instability of Chinese hamster ovary cell lines expressing recombinant antibodies and antibody-fusion proteins. Biotechnol. Bioeng. 109: 1016–1030.
Wurm, F. M. and M. J. Wurm (2017) Cloning of CHO cells, productivity and genetic stability—a discussion. Processes 5: 20.
Baik, J. Y. and K. H. Lee (2017) A framework to quantify karyotype variation associated with CHO cell line instability at a single-cell level. Biotechnol. Bioeng. 114: 1045–1053.
Mizrahi, R. A., W. Y. Lin, A. Gras, A. R. Niedecken, E. K. Wagner, S. M. Keating, N. Ikon, V. A. Manickam, M. A. Asensio, J. Leong, A. V. Medina-Cucurella, E. Benzie, K. P. Carter, Y. Chiang, R. C. Edgar, R. Leong, Y. W. Lim, J. F. Simons, M. J. Spindler, K. Stadtmiller, N. Wayham, D. Büscher, J. V. Terencio, C. D. Germanio, S. M. Chamow, C. Olson, P. A. Pino, J.-G. Park, A. Hicks, C. Ye, A. Garcia-Vilanova, L. Martinez-Sobrido, J. B. Torrelles, D. S. Johnson, and A. S. Adler (2022) GMP manufacturing and IND-enabling studies of a recombinant hyperimmune globulin targeting SARS-CoV-2. Pathogens 11: 806.
Torres, M., Z. Betts, R. Scholey, M. Elvin, S. Place, A. Hayes, and A. J. Dickson (2023) Long term culture promotes changes to growth, gene expression, and metabolism in CHO cells that are independent of production stability. Biotechnol. Bioeng.https://doi.org/10.1002/bit.28399
Hong, J. K., M. Lakshmanan, C. Goudar, and D.-Y. Lee (2018) Towards next generation CHO cell line development and engineering by systems approaches. Curr. Opin. Chem. Eng. 22: 1–10.
Vcelar, S., M. Melcher, N. Auer, A. Hrdina, A. Puklowski, F. Leisch, V. Jadhav, T. Wenger, M. Baumann, and N. Borth (2018) Changes in chromosome counts and patterns in CHO cell lines upon generation of recombinant cell lines and subcloning. Biotechnol. J. 13: e1700495.
Turilova, V. I., T. S. Goryachaya, and T. K. Yakovleva (2021) Chinese hamster ovary cell line DXB-11: chromosomal instability and karyotype heterogeneity. Mol. Cytogenet. 14: 11.
Lewis, N. E., X. Liu, Y. Li, H. Nagarajan, G. Yerganian, E. O’Brien, A. Bordbar, A. M. Roth, J. Rosenbloom, C. Bian, M. Xie, W. Chen, N. Li, D. Baycin-Hizal, H. Latif, J. Forster, M. J. Betenbaugh, I. Famili, X. Xu, J. Wang, and B. O. Palsson (2013) Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat. Biotechnol. 31: 759–765.
Dhiman, H., M. P. Gerstl, D. Ruckerbauer, M. Hanscho, H. Himmelbauer, C. Clarke, N. Barron, J. Zanghellini, and N. Borth (2019) Genetic and epigenetic variation across genes involved in energy metabolism and mitochondria of Chinese hamster ovary cell lines. Biotechnol. J. 14: e1800681.
Wurm, F. M. and D. Hacker (2011) First CHO genome. Nat. Biotechnol. 29: 718–720.
Vcelar, S., V. Jadhav, M. Melcher, N. Auer, A. Hrdina, R. Sagmeister, K. Heffner, A. Puklowski, M. Betenbaugh, T. Wenger, F. Leisch, M. Baumann, and N. Borth (2018) Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting. Biotechnol. Bioeng. 115: 165–173.
Xu, X., H. Nagarajan, N. E. Lewis, S. Pan, Z. Cai, X. Liu, W. Chen, M. Xie, W. Wang, S. Hammond, M. R. Andersen, N. Neff, B. Passarelli, W. Koh, H. C. Fan, J. Wang, Y. Gui, K. H. Lee, M. J. Betenbaugh, S. R. Quake, I. Famili, B. O. Palsson, and J. Wang (2011) The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat. Biotechnol. 29: 735–741.
Kaas, C. S., C. Kristensen, M. J. Betenbaugh, and M. R. Andersen (2015) Sequencing the CHO DXB11 genome reveals regional variations in genomic stability and haploidy. BMC Genomics 16:160.
Cao, Y., S. Kimura, T. Itoi, K. Honda, H. Ohtake, and T. Omasa (2012) Construction of BAC-based physical map and analysis of chromosome rearrangement in Chinese hamster ovary cell lines. Biotechnol. Bioeng. 109: 1357–1367.
Reinhart, D., L. Damjanovic, C. Kaisermayer, W. Sommeregger, A. Gili, B. Gasselhuber, A. Castan, P. Mayrhofer, C. Grünwald-Gruber, and R. Kunert (2019) Bioprocessing of recombinant CHO-K1, CHO-DG44, and CHO-S: CHO expression hosts favor either mAb production or biomass synthesis. Biotechnol. J. 14: e1700686.
Bandyopadhyay, A. A., S. A. O’Brien, L. Zhao, H.-Y. Fu, N. Vishwanathan, and W.-S. Hu (2019) Recurring genomic structural variation leads to clonal instability and loss of productivity. Biotechnol. Bioeng. 116: 41–53.
Qian, Y., S. W. Sowa, K. L. Aron, P. Xu, E. Langsdorf, B. Warrack, N. Aranibar, G. Tremml, J. Xu, D. McVey, M. Reily, A. Khetan, M. C. Borys, and Z. J. Li (2020) New insights into genetic instability of an industrial CHO cell line by orthogonal omics. Biochem. Eng. J. 164: 107799.
Veith, N., H. Ziehr, R. A. MacLeod, and S. M. Reamon-Buettner (2016) Mechanisms underlying epigenetic and transcriptional heterogeneity in Chinese hamster ovary (CHO) cell lines. BMC Biotechnol. 16: 6.
Moore, L. D., T. Le, and G. Fan (2013) DNA methylation and its basic function. Neuropsychopharmacology 38: 23–38.
Yang, Y., Mariati, J. Chusainow, and M. G. Yap (2010) DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. J. Biotechnol. 147: 180–185.
Marx, N., P. Eisenhut, M. Weinguny, G. Klanert, and N. Borth (2022) How to train your cell - Towards controlling phenotypes by harnessing the epigenome of Chinese hamster ovary production cell lines. Biotechnol. Adv. 56: 107924.
Kim, M., P. M. O’Callaghan, K. A. Droms, and D. C. James (2011) A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol. Bioeng. 108: 2434–2446.
Osterlehner, A., S. Simmeth, and U. Göpfert (2011) Promoter methylation and transgene copy numbers predict unstable protein production in recombinant Chinese hamster ovary cell lines. Biotechnol. Bioeng. 108: 2670–2681.
Paredes, V., J. S. Park, Y. Jeong, J. Yoon, and K. Baek (2013) Unstable expression of recombinant antibody during long-term culture of CHO cells is accompanied by histone H3 hypoacetylation. Biotechnol. Lett. 35: 987–993.
Moritz, B., L. Woltering, P. B. Becker, and U. Göpfert (2016) High levels of histone H3 acetylation at the CMV promoter are predictive of stable expression in Chinese hamster ovary cells. Biotechnol. Prog. 32: 776–786.
Kaikkonen, M. U., M. T. Lam, and C. K. Glass (2011) Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 90: 430–440.
Fernandes, J. C. R., S. M. Acuña, J. I. Aoki, L. M. Floeter-Winter, and S. M. Muxel (2019) Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA 5: 17.
Vito, D., J. C. Eriksen, C. Skjødt, D. Weilguny, S. K. Rasmussen, and C. M. Smales (2020) Defining lncRNAs correlated with CHO cell growth and IgG productivity by RNA-seq. iScience 23:100785.
Motheramgari, K., R. Valdés-Bango Curell, I. Tzani, C. Gallagher, M. Castro-Rivadeneyra, L. Zhang, N. Barron, and C. Clarke (2020) Expanding the Chinese hamster ovary cell long noncoding RNA transcriptome using RNASeq. Biotechnol. Bioeng. 117: 3224–3231.
Vito, D. and C. M. Smales (2018) The long non-coding RNA transcriptome landscape in CHO cells under batch and fed-batch conditions. Biotechnol. J. 13: e1800122.
Urlaub, G., E. Käs, A. M. Carothers, and L. A. Chasin (1983) Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 33: 405–412.
Fan, L., I. Kadura, L. E. Krebs, C. C. Hatfield, M. M. Shaw, and C. C. Frye (2012) Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Biotechnol. Bioeng. 109: 1007–1015.
Noh, S. M., S. Shin, and G. M. Lee (2018) Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies. Sci. Rep. 8: 5361.
Kim, N. S., S. J. Kim, and G. M. Lee (1998) Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. Biotechnol. Bioeng. 60: 679–688.
Jiang, Z., Y. Huang, and S. T. Sharfstein (2006) Regulation of recombinant monoclonal antibody production in Chinese hamster ovary cells: a comparative study of gene copy number, mRNA level, and protein expression. Biotechnol. Prog. 22: 313–318.
Fann, C. H., F. Guirgis, G. Chen, M. S. Lao, and J. M. Piret (2000) Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells. Biotechnol. Bioeng. 69: 204–212.
Tharmalingam, T., H. Barkhordarian, N. Tejeda, K. Daris, S. Yaghmour, P. Yam, F. Lu, C. Goudar, T. Munro, and J. Stevens (2018) Characterization of phenotypic and genotypic diversity in subclones derived from a clonal cell line. Biotechnol. Prog. 34:613–623.
Spahn, P. N., X. Zhang, Q. Hu, H. Lu, N. K. Hamaker, H. Hefzi, S. Li, C.-C. Kuo, Y. Huang, J. C. Lee, A. J. Davis, P. Ly, K. H. Lee, and N. E. Lewis (2022) Restoration of DNA repair mitigates genome instability and increases productivity of Chinese hamster ovary cells. Biotechnol. Bioeng. 119: 963–982.
Ritter, A., B. Voedisch, J. Wienberg, B. Wilms, S. Geisse, T. Jostock, and H. Laux (2016) Deletion of a telomeric region on chromosome 8 correlates with higher productivity and stability of CHO cell lines. Biotechnol. Bioeng. 113: 1084–1093.
Ritter, A., S. Nuciforo, A. Schulze, M. Oertli, T. Rauschert, B. Voedisch, S. Geisse, T. Jostock, and H. Laux (2017) Fam60A plays a role for production stabilities of recombinant CHO cell lines. Biotechnol. Bioeng. 114: 701–704.
Ritter, A., T. Rauschert, M. Oertli, D. Piehlmaier, P. Mantas, G. Kuntzelmann, N. Lageyre, B. Brannetti, B. Voedisch, S. Geisse, T. Jostock, and H. Laux (2016) Disruption of the gene C12orf35 leads to increased productivities in recombinant CHO cell lines. Biotechnol. Bioeng. 113: 2433–2442.
Marx, N., C. Grünwald-Gruber, N. Bydlinski, H. Dhiman, L. Ngoc Nguyen, G. Klanert, and N. Borth (2018) CRISPR-based targeted epigenetic editing enables gene expression modulation of the silenced beta-galactoside alpha-2, 6-sialyltransferase 1 in CHO cells. Biotechnol. J. 13: e1700217.
Marx, N., H. Dhiman, V. Schmieder, C. M. Freire, L. N. Nguyen, G. Klanert, and N. Borth (2021) Enhanced targeted DNA methylation of the CMV and endogenous promoters with dCas9-DNMT3A3L entails distinct subsequent histone modification changes in CHO cells. Metab. Eng. 66: 268–282.
Wang, W., X. Guo, Y.-M. Li, X.-Y. Wang, X.-J. Yang, Y.-F. Wang, and T.-Y. Wang (2018) Enhanced transgene expression using cis-acting elements combined with the EF1 promoter in a mammalian expression system. Eur. J. Pharm. Sci. 123: 539–545.
Heng, H. H., S. Goetze, C. J. Ye, G. Liu, J. B. Stevens, S. W. Bremer, S. M. Wykes, J. Bode, and S. A. Krawetz (2004) Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J. Cell Sci. 117: 999–1008.
Jia, Y.-L., X. Guo, X.-C. Wang, and T.-Y. Wang (2019) Human genome-derived TOP1 matrix attachment region enhances transgene expression in the transfected CHO cells. Biotechnol. Lett. 41: 701–709.
Ho, S. C., Mariati, J. H. Yeo, S. G. Fang, and Y. Yang (2015) Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells. Mol. Biotechnol. 57: 138–144.”
Tian, Z.-W., D.-H. Xu, T.-Y. Wang, X.-Y. Wang, H.-Y. Xu, C.-P. Zhao, and G.-H. Xu (2018) Identification of a potent MAR element from the human genome and assessment of its activity in stably transfected CHO cells. J. Cell. Mol. Med. 22: 1095–1102.
Saunders, F., B. Sweeney, M. N. Antoniou, P. Stephens, and K. Cain (2015) Chromatin function modifying elements in an industrial antibody production platform—comparison of UCOE, MAR, STAR and cHS4 elements. PLoS One 10: e0120096.
Nematpour, F., F. Mahboudi, B. Vaziri, V. Khalaj, S. Ahmadi, M. Ahmadi, S. Ebadat, and F. Davami (2017) Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells. BMC Biotechnol. 17:18.
Kwaks, T. H., P. Barnett, W. Hemrika, T. Siersma, R. G. Sewalt, D. P. Satijn, J. F. Brons, R. van Blokland, P. Kwakman, A. L. Kruckeberg, A. Kelder, and A. P. Otte (2003) Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat. Biotechnol. 21: 553–558.
Wang, W., X. Guo, S.-J. Chen, T.-Y. Wang, F. Wang, Q. Li, and Y.-F. Wang (2020) Effects of viral promoters, the Woodchuck hepatitis post-transcriptional regulatory element, and weakened antibiotic resistance markers on transgene expression in Chinese hamster ovary cells. Process Biochem. 94: 258–265.
Nair, A. R., X. Jinger, and T. W. Hermiston (2011) Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII. BMC Res. Notes 4:178.
Sadelain, M., E. P. Papapetrou, and F. D. Bushman (2012) Safe harbours for the integration of new DNA in the human genome. Nat. Rev. Cancer 12: 51–58.
Zambrowicz, B. P., A. Imamoto, S. Fiering, L. A. Herzenberg, W. G. Kerr, and P. Soriano (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 94: 3789–3794.
Gaidukov, L., L. Wroblewska, B. Teague, T. Nelson, X. Zhang, Y. Liu, K. Jagtap, S. Mamo, W. A. Tseng, A. Lowe, J. Das, K. Bandara, S. Baijuraj, N. M. Summers, T. K. Lu, L. Zhang, and R. Weiss (2018) A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res. 46: 4072–4086.
Zhou, S., X. Ding, L. Yang, Y. Chen, X. Gong, J. Jin, and H. Li (2019) Discovery of a stable expression hot spot in the genome of Chinese hamster ovary cells using lentivirus-based random integration. Biotechnol. Biotechnol. Equip. 33: 605–612.
Lee, Z., M. Raabe, and W.-S. Hu (2021) Epigenomic features revealed by ATAC-seq impact transgene expression in CHO cells. Biotechnol. Bioeng. 118: 1851–1861.
Kito, M., S. Itami, Y. Fukano, K. Yamana, and T. Shibui (2002) Construction of engineered CHO strains for high-level production of recombinant proteins. Appl. Microbiol. Biotechnol. 60: 442–448.
Lieu, P. T., T. Machleidt, B. Thyagarajan, A. Fontes, E. Frey, M. Fuerstenau-Sharp, D. V. Thompson, G. M. Swamilingiah, S. S. Derebail, D. Piper, and J. D. Chesnut (2009) Generation of site-specific retargeting platform cell lines for drug discovery using phiC31 and R4 integrases. J. Biomol. Screen. 14: 1207–1215.
Inniss, M. C., K. Bandara, B. Jusiak, T. K. Lu, R. Weiss, L. Wroblewska, and L. Zhang (2017) A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO cells. Biotechnol. Bioeng. 114: 1837–1846.
Huang, Y., Y. Li, Y. G. Wang, X. Gu, Y. Wang, and B. F. Shen (2007) An efficient and targeted gene integration system for high-level antibody expression. J. Immunol. Methods 322: 28–39.
Oliviero, C., S. C. Hinz, J. P. Bogen, H. Kornmann, B. Hock, H. Kolmar, and G. Hagens (2022) Generation of a host cell line containing a MAR-rich landing pad for site-specific integration and expression of transgenes. Biotechnol. Prog. 38: e3254.
Sergeeva, D., G. M. Lee, L. K. Nielsen, and L. M. Grav (2020) Multicopy targeted integration for accelerated development of high-producing Chinese hamster ovary cells. ACS Synth. Biol. 9:2546–2561.
Altamura, R., J. Doshi, and Y. Benenson (2022) Rational design and construction of multi-copy biomanufacturing islands in mammalian cells. Nucleic Acids Res. 50: 561–578.
Lieske, P. L., W. Wei, K. B. Crowe, B. Figueroa, and L. Zhang (2020) HIF-1 signaling pathway implicated in phenotypic instability in a Chinese hamster ovary production cell line. Biotechnol. J. 15: e1900306.
Tzani, I., N. Herrmann, S. Carillo, C. A. Spargo, R. Hagan, N. Barron, J. Bones, W. Shannon Dillmore, and C. Clarke (2021) Tracing production instability in a clonally derived CHO cell line using single-cell transcriptomics. Biotechnol. Bioeng. 118: 2016–2030.
Bailey, L. A., D. Hatton, R. Field, and A. J. Dickson (2012) Determination of Chinese hamster ovary cell line stability and recombinant antibody expression during long-term culture. Biotechnol. Bioeng. 109: 2093–2103.
Chitwood, D. G., Q. Wang, K. Elliott, A. Bullock, D. Jordana, Z. Li, C. Wu, S. W. Harcum, and C. A. Saski (2021) Characterization of metabolic responses, genetic variations, and microsatellite instability in ammonia-stressed CHO cells grown in fed-batch cultures. BMC Biotechnol. 21: 4.
Dobson, P. D., K. P. Coss, C. Doherty, J. Clifford, B. Thompson, and D. C. James (2020) Cell function profiling to assess clone stability. Biotechnol. Bioeng. 117: 2295–2299.
Acknowledgements
This work was supported by Inha University Research Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
Neither ethical approval nor informed consent was required for this study.
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Joo, Y., Kim, H. & Baik, J.Y. Chinese Hamster Ovary Cell Line Instability: Causes, Mitigation, and Prediction. Biotechnol Bioproc E 28, 750–760 (2023). https://doi.org/10.1007/s12257-023-0120-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-023-0120-6